📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Safety, immunogenicity and effect on viral rebound of HTI vaccines in early treated HIV-1 infection: a randomized, placebo-controlled phase 1 trial. (2022)

First Author: Bailón L

Attributed to: Definition and induction of broadly protective responses against HIV-1 funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s41591-022-02060-2

PubMed Identifier: 36302893

Publication URI: http://europepmc.org/abstract/MED/36302893

Type: Journal Article/Review

Volume: 28

Parent Publication: Nature medicine

Issue: 12

ISSN: 1078-8956